Advertisement

Topics

Numis Securities Limited Company Profile

10:23 EDT 26th September 2018 | BioPortfolio

Numis Securities Limited ("Numis") is a rapidly growing investment banking and institutional stockbroking business providing a premium service to corporate and institutional clients. It is the trading subsidiary of Numis Corporation Plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange Our aim is to provide a premium service to our corporate and institutional clients. We do not provide services to individual private customers.
Our services are research driven and concentrate on UK market sectors in which we have proven expertise. They comprise a full range of Corporate Finance, Institutional Stockbroking, Market Making and Research services. As well as our head office in Cheapside in the City of London we are represented in Liverpool, where our analysts and specialist sales team covering the Consumer sector are located and where part of our Speciality Financials expertise can be found

Location

Cheapside House138 Cheapside
London
London
EC2V 6LH
United Kingdom

Contact

Phone: 020 7776 1500


News Articles [208 Associated News Articles listed on BioPortfolio]

Numis Securities tempers recommendation on Ocado following “solid” trading update

Numis analysts said: “Although we lower our recommendation from Buy to Add today to reflect the strong move in the share price (+130% over the last 4m), we remain positive"

Numis Securities cuts Indivior to ‘hold’ from ‘buy’ on effects of copycat drug on sales and profits

Numis’s analysts said: “We now expect significant further downgrades to FY18 EPS (c.20) with US$25mln of cost savings targeted and substantial downgrades to FY19 forecasts c.50% … on the slower ...

Numis Securities cuts Indivior to ‘hold’ from ‘buy’ in the wake of copycat drug impact sales and profit warning

Numis’s analysts said: “We now expect significant further downgrades to FY18 EPS (c.20) with US$25mln of cost savings targeted and substantial downgrades to FY19 forecasts c.50% … on the slower ...

Numis upgrades DS Smith to ‘add’ as packaging group accelerates earnings momentum

In a note to clients, analysts at Numis said the proposed acquisition of Spanish Europac for an enterprise value of €1.9bn will strengthen Iberian and French market presence

Indivior's dive puts it into buying territory, Numis believes

In the last six weeks or so, the share price of Indivior has plunged from 493p to 306p and that's a level at which Numis thinks the upside risk outweighs the downside.

Ocado to secure more partnerships after bagging deal with Sweden's ICA, says Numis

Numis upgraded its rating on Ocado to ‘buy’ from ‘add’, saying it believes Ocado is building a “very valuable business”.

EMIS has fallen too far, says house broker Numis Securities

CEO Andy Thorburn is focused for now on improving underlying operating procedures and performance, including a focus on the replacement GP systems contract for England, now perhaps 15-18 months away

Numis Securities trims rating for Hikma Pharmaceuticals to ‘add’ from ‘buy’ on valuation grounds after update

The City broker, however, raised its target price for the FTSE 250-listed firm to 1,560p, up from 1,300p previously after updating its sum-of-the parts valuation for the group

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Conjugate Vaccine Against Meningococcus C a Brazilian Project

TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blind, national multi-center, with a total of 1,644 research participants stratified into 3 groups according to age f...

Companies [228 Associated Companies listed on BioPortfolio]

Numis Securities Limited

Numis Securities Limited ("Numis") is a rapidly growing investment banking and institutional stockbroking business providing a premium service to corporate and institutional clients. It is the trading...

Hilltop Securities Inc.

Hilltop Securities Inc., a member of NYSE, FINRA and SIPC, delivers the forthright advice and tailored solutions necessary for municipal issuers, institutions, broker-dealers and ...

Seaview Securities LLC

Seaview Securities LLC is a specialty investment bank assisting life sciences companies with private placements, public offerings, M&A and strategic advice.

Klayman & Toskes, PA

K&T is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation, on behalf of retail and institutional investors th...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "Numis Securities Limited" on BioPortfolio

We have published hundreds of Numis Securities Limited news stories on BioPortfolio along with dozens of Numis Securities Limited Clinical Trials and PubMed Articles about Numis Securities Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Numis Securities Limited Companies in our database. You can also find out about relevant Numis Securities Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record